Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production

Vaccine

Volumn 29, Issue 47, 2011, Pages 8661-8668

  Coussens, Paul M ^a   Smith, Kristen A ^a   Weber, Patty S D ^a   Colvin, Christopher J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Influenza; Serum free; Vaccine production

Indexed keywords

PROTEINASE;

ADAPTATION; ANIMAL CELL; ANTIGENICITY; ARTICLE; CELL IMMORTALIZATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; RECEPTOR BINDING; VACCINE PRODUCTION; VERO CELL; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CHICK EMBRYO; CULTURE MEDIA, SERUM-FREE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; VIRAL LOAD; VIRUS CULTIVATION;

EID: 82455218961     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.122     Document Type: Article

References (22)

1. Robertson J.S., Cook P., Attwell A.M., Williams S.P. Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture. Vaccine 1995, 13(16):1583-1588.
2. Genzel Y., Fischer M., Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 2006, 24(16):3261-3272.
3. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 2001, 19(25-26):3444-3450.
4. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998, 16(9-10):960-968.
5. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19(17-19):2716-2721.
6. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 1999, 258(2):232-239.
7. Bardiya N., Bae J.H. Influenza vaccines: recent advances in production technologies. Applied Microbiology and Biotechnology 2005, 67(3):299-305.
8. Katz J.M., Webster R.G. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. Virology 1988, 165(2):446-456.
9. Schild G.C., Oxford J.S., de Jong J.C., Webster R.G. Evidence for host-cell selection of influenza virus antigenic variants. Nature 1983, 303(5919):706-709.
10. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Daniels R.S., Webster R.G., et al. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 1987, 160(1):31-37.
11. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. Journal of Virology 1997, 71(4):3357-3362.
12. Ogura H., Fujiwara T. Establishment and characterization of a virus-free chick cell line. Acta Medica Okayama 1987, 41(3):141-143.
13. Govorkova E.A., Murti G., Meignier B., de Taisne C., Webster R.G. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. Journal of Virology 1996, 70(8):5519-5524.
14. Govorkova E.A., Matrosovich M.N., Tuzikov A.B., Bovin N.V., Gerdil C., Fanget B., et al. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology 1999, 262(1):31-38.
15. Szretter KJ, Balish AL, Katz JM. Orthomyxoviruses; influenza: propagation, quantification, and storage. Current protocols in microbiology; 2006. p. 15G.1.1-G.1.22.
16. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Hypertension 1937, 27(3):493-497.
17. Lee E.U., Roth J., Paulson J.C. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase. The Journal of Biological Chemistry 1989, 264(23):13848-13855.
18. Rimmelzwaan G.F., Baars M., Claas E.C., Osterhaus A.D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. Journal of Virological Methods 1998, 74(1):57-66.
19. Masurel N., Ophof P., de Jong P. Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. The Journal of Hygiene 1981, 87(2):201-209.
20. Kaverin N.V., Webster R.G. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. Journal of Virology 1995, 69(4):2700-2703.
21. Nayak D.P. Defective interfering influenza viruses. Annual Review of Microbiology 1980, 34:619-644.
22. Smith K.A., Colvin C.J., Weber P.S.D., Spatz S., Coussens P.M. High titer growth of avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases. Vaccine 2008, 26:3778-3782.